Frequency News and Research

RSS

Older adults can be more focused, less mentally restless than younger adults

New research from Trinity College Dublin suggests that older adults can be more focused, less impeded by anxiety and less mentally restless than younger adults.

11 Feb 2021

Playing sport during COVID-19 pandemic eased anxiety and depression for students

School sports came to an abrupt halt during the COVID-19 (coronavirus disease 2019) pandemic. How this impacted adolescents' health, who were otherwise generally active in sports in their school, is examined in new research. What happened when adolescent athletes returned to organized sport in this pandemic?

10 Feb 2021

Study finds low SARS-CoV-2 antibody responses in asymptomatic and mild COVID-19 cases

Researchers at Northwestern University have noted high rates of asymptomatic and mild infection in a large community-based cohort and low levels of anti-SARS-CoV-2 immunoglobulin G antibody (IgG) in the general population of previously exposed people.

10 Feb 2021

Drinking one or more cups of caffeinated coffee may reduce heart failure risk

Dietary information from three large, well-known heart disease studies suggests drinking one or more cups of caffeinated coffee may reduce heart failure risk, according to research published today in Circulation: Heart Failure, an American Heart Association journal.

9 Feb 2021

Subgenomic RNAs could help identify asymptomatic SARS-CoV-2 infection

Researchers report the association of subgenomic RNA (sgRNA) production, the structural differences between sgRNA variants, and clinical severity in 81 clinical specimens obtained from both asymptomatic and symptomatic individuals with SARS-CoV-2 infection.

9 Feb 2021

Emergence and transmission of UK SARS-CoV-2 variant in the US

Researchers describe the impending rise to dominance of the B.1.1.7 (UK) variant in the US. Understanding this development will help to shape preventive action to reduce the infection and mortality rates.

9 Feb 2021

Bioengineered ankyrin compounds show high in vitro activity against SARS-CoV-2 mutants

A new study describes the use of DARPin (designed ankyrin repeat proteins) therapeutic agents, each of which contains three different DARPin domains within the same molecule.

8 Feb 2021

SARS-CoV-2 escape mutations identified against monoclonal antibodies and polyclonal immune sera

A recent study describes the experimental selection of SARS-CoV-2 mutants associated with resistance to antibodies, with important implications for vaccine development and therapeutic antibody use.

8 Feb 2021

Molecular surveillance of SARS-CoV-2 spike protein mutations using CovRadar

In a recent bioRxiv preprint research paper, scientists from Germany discuss how they made sequence information more easily accessible for epidemiologists and virologists.

7 Feb 2021

Study: Only 14% of the Bernese population developed antibodies against SARS-CoV-2

In the canton of Bern, only 14% of the adult population were infected with the coronavirus and developed antibodies against SARS-CoV-2.

4 Feb 2021

Resonance-guided vaporization may provide new ways of treating tumors

Sending tiny droplets to a tumor and having them vaporized using focused ultrasound: it could be a new way of tracing a tumor or deliver drugs locally.

4 Feb 2021

Study highlights barriers faced by cancer survivors in maintaining a healthy diet

The Journal of the Academy of Nutrition and Dietetics focuses on the relationship between diet and cancer and the role nutrition may play in successful cancer outcomes.

4 Feb 2021

Gene mutations may explain the poorer outcomes in Hispanic and Latino children with leukemia

A combination of genetic mutations may explain the higher incidence of and poorer outcomes from pediatric leukemia in Hispanic and Latino children, according to Penn State College of Medicine researchers.

2 Feb 2021

Previous SARS-CoV-2 infection may negate need for two vaccine doses

Researchers in the United States have shown that two doses of vaccine may not be necessary to protect against coronavirus disease 2019 (COVID-19) among people who have already been infected with the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

2 Feb 2021

Study: MRI is reliable for intrapelvic T staging of neuroendocrine carcinoma

Oncotarget recently published "Neuroendocrine carcinoma of uterine cervix findings shown by MRI for staging and survival analysis – Japan multicenter study" which reported that to investigate neuroendocrine carcinoma of the uterine cervix cases for MRI features and staging, as well as pathological correlations and survival.

2 Feb 2021

Research shows a promising alternative to personalized deep brain stimulation

Millions of patients suffering from neurological and mental disorders such as depression, addiction, and chronic pain are treatment-resistant. In fact, about 30% of all major depression patients do not respond at all to any medication or psychotherapy.

2 Feb 2021

Study explains why people of African descent are less likely to find bone marrow donors

A paper by a multidisciplinary team of scientists affiliated with various Brazilian institutions, including the University of São Paulo (USP) and the National Cancer Institute (INCA), shows that people of African descent are less likely to find a donor in the National Register of Voluntary Bone Marrow Donors (REDOME) than people with predominantly European ancestry.

1 Feb 2021

High national prevalence of SARS-CoV-2 with regional variability in England, REACT-1 survey finds

The REACT-1 survey conducted in the United Kingdom demonstrates a high average prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in England during January 2021. The survey also indicates that a sustained reduction in infection prevalence is urgently needed to avoid burden on healthcare systems and reduce coronavirus disease 2019 (COVID-19)-related mortality.

1 Feb 2021

Granulocyte changes could help predict patient outcomes in COVID-19

Researchers in Sweden have provided a comprehensive characterization of circulating granulocytes in people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

1 Feb 2021

Colchicine may have therapeutic potential against COVID-19

A new study describes the results of colchicine in mitigating the inflammatory storm associated with COVID-19, and thus preventing a percentage of severe and critical cases.

1 Feb 2021

Frequency News and Research

Older adults can be more focused, less mentally restless than younger adults

Playing sport during COVID-19 pandemic eased anxiety and depression for students

Study finds low SARS-CoV-2 antibody responses in asymptomatic and mild COVID-19 cases

Drinking one or more cups of caffeinated coffee may reduce heart failure risk

Subgenomic RNAs could help identify asymptomatic SARS-CoV-2 infection

Emergence and transmission of UK SARS-CoV-2 variant in the US

Bioengineered ankyrin compounds show high in vitro activity against SARS-CoV-2 mutants

SARS-CoV-2 escape mutations identified against monoclonal antibodies and polyclonal immune sera

Molecular surveillance of SARS-CoV-2 spike protein mutations using CovRadar

Study: Only 14% of the Bernese population developed antibodies against SARS-CoV-2

Resonance-guided vaporization may provide new ways of treating tumors

Study highlights barriers faced by cancer survivors in maintaining a healthy diet

Gene mutations may explain the poorer outcomes in Hispanic and Latino children with leukemia

Previous SARS-CoV-2 infection may negate need for two vaccine doses

Study: MRI is reliable for intrapelvic T staging of neuroendocrine carcinoma

Research shows a promising alternative to personalized deep brain stimulation

Study explains why people of African descent are less likely to find bone marrow donors

High national prevalence of SARS-CoV-2 with regional variability in England, REACT-1 survey finds

Granulocyte changes could help predict patient outcomes in COVID-19

Colchicine may have therapeutic potential against COVID-19

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News